Form 4/A for CATX Perspective Therapeutics, Inc.
Accepted 2022-09-22 00:00:00 ET · period of report 2022-08-18 · accession 0001437749-22-022927 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-09-22 | 2022-08-18 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.43 | +50.0K | 77.9K | +179% | +$21.5K |
| DA | 2022-09-22 | 2022-08-18 | CATX | Streeter Jennifer | COO, VP of HR | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-18 | M | A | 50,000 | $0.43 | 77,940 | D | — | — | (F2) The previous Form 4 incorrectly stated 87,940 shares owned, but should have stated 77,940 shares owned. |
| 2 | Derivative | Stock Options (right to buy) | 2022-08-18 | M | D | 50,000 | $0.00 | 0 | D | $0.43 · — to 2029-06-18 | 100,000 Common Stock | (F1) 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. |